Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

 This is in reference with the Scheme of Amalgamation of Gufic Biosciences Limited ('the Company') with Gufic Lifesciences Private Limited ('GLPL') and their respective shareholders and creditors, for which 'No Observation Letters' have been received by BSE Limited and National Stock Exchange of India Limited vide their letters dated April 15, 2020.We are pleased to inform you that GLPL have been approved by South African Health Products Regulatory Authority (SAHPRA) to manufacture Vancomycin Inj 500mg and Vancomycin Inj 1gm, after its manufacturing facility situated at Navsari, Gujarat been inspected by the Competent Authority of Hungary, National Institute of Pharmacy and Nutrition and with this approval, GLPL can now expand its business in the territory of South Africa.
09-07-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the cutting of Newspaper published today in Business Standard (English Edition) and Mumbai Lakswadeep ( Marathi Edition) in accordance with Rule 6 of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended from time to time ('IEPF Rules'), inviting attention of concerned shareholders to submit their claims in respect of unclaimed dividends of the Company for last seven consecutive years failing which their shares would be transferred to IEPF Authority in accordance with Section 124(6) of the Companies Act, 2013 and rules made thereunder.
08-07-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

 This is in furtherance to our letter dated April 16, 2020 intimating about the approval received for the Scheme of Amalgamation of Gufic Lifesciences Private Limited (the 'Transferor Company') with Gufic Biosciences Limited (the 'Transferee Company' or 'Company') and their respective shareholders and creditors from BSE Limited and National Stock Exchange of India Limited vide their Observation Letters dated April 15, 2020. Kindly be informed that the Transferor Company and the Transferee Company have applied for the approval of the said Scheme before the Hon'ble National Company Law Tribunal, Mumbai Bench and Ahmadabad Bench respectively, for further processing. Any further developments in this regards shall be duly intimated.
03-07-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Non-Applicability Of SEBI Circular (SEBI/H0/DDHS/CIR/P/2018/144) Dated November 26, 2018 With Respect To Fund Raising By Issuance Of Debt Securities By Large Corporates

 We would like to inform you that Gufic Biosciences Limited is not falling under category of "Large Corporate" as per the applicability criteria mentioned under the SEBI Circular No. SEBl/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 with respect to fund raising by issuance of Debt Securities by Large Corporates.
11-06-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to the provisions of Regulation 40(9) of SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith certificate received from M/s. Gajanan D. Athavale, Practicing Company Secretary, Mumbai for the half year ended March 31,2020.
25-05-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Compliance Certificate For The Period Of Half Year Ended March 31, 2020

 As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period October 1, 2019 to March 31, 2020 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number : INR000004058.
18-05-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Shareholding for the Period Ended March 31, 2020

 Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
07-05-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

 This is in reference with the Scheme of Amalgamation of Gufic Biosciences Limited ('the Company') with Gufic Lifesciences Private Limited ('GLPL') and their respective shareholders and creditors, for which 'Observation Letters' with no adverse remarks have been received by BSE Limited and National Stock Exchange of India Limited vide their letters dated April 15, 2020. We are pleased to inform you that GLPL have been approved by ANVISA, Brazil and with this approval, GLPL can now expand its business in the territory of Brazil.
24-04-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 This is to certify that the securities received for dematerialization during the aforesaid period as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, have been furnished to all the stock exchanges where the shares of the Company are listed. The letter confirming the above as received from our Registrar and Share Transfer Agent, M/s Link Intime India Private Limited is enclosed herewith.
21-04-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Statement Of Investor Complaints For The Quarter Ended March 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ami ShahDesignation :- Company Secretary and Compliance Officer
21-04-2020
Next Page
Close

Let's Open Free Demat Account